Institutional Ownership Sorrento Therapeutics, Inc. (SRNE)
This table provides information about the institutional ownership of Sorrento Therapeutics, Inc. (SRNE). We have compiled data on the 12 institutions that hold shares in the stock, with a total of 5.47 Million shares, which have been reported (via 13F filing form) to have a value of $1.8 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
B. Riley Securities, Inc.
Los Angeles, CA |
Feb 07, 2023 Q4 2022 |
5,216,250
shares
|
$1.72 Million
1.01% of portfolio
|
Q4 2022
New holding
|
|
|
Swisspartners Ltd.
Vaduz, N2 |
Feb 14, 2023 Q4 2022 |
110,000
shares
|
$36,300
0.12% of portfolio
|
Q1 2022
Added 160.45%
|
|
|
Lattice Capital Management, LLC
|
Nov 13, 2024 Q3 2024 |
51,800
shares
|
$17,094
0.02% of portfolio
|
Q4 2023
New holding
|
|
|
High Point Advisor Group LLC
Downers Grove, IL |
Nov 04, 2024 Q3 2024 |
22,250
shares
|
$7,342
0.0% of portfolio
|
Q3 2024
New holding
|
|
|
Slate Stone Wealth, LLC
|
Nov 07, 2024 Q3 2024 |
21,433
shares
|
$7,072
0.0% of portfolio
|
Q4 2023
Reduced 30.56%
|
|
|
Frontier Wealth Management LLC
Kansas City, MO |
Aug 12, 2022 Q2 2022 |
20,500
shares
|
$6,765
0.0% of portfolio
|
Q2 2022
Reduced 48.78%
|
|
|
Corient Capital Partners, LLC
Newport Beach, CA |
Nov 14, 2022 Q3 2022 |
14,913
shares
|
$4,921
0.0% of portfolio
|
Q2 2022
New holding
|
|
|
Huntington National Bank
Columbus, OH |
Nov 06, 2024 Q3 2024 |
5,001
shares
|
$1,650
0.0% of portfolio
|
Q4 2023
Reduced 66.66%
|
|
|
American Portfolios Advisors
Holbrook, NY |
Mar 17, 2023 Q3 2022 |
4,350
shares
|
$1,435
0.0% of portfolio
|
Q2 2020
Added 24.71%
|
|
|
Wipfli Financial Advisors Llc,
|
Oct 26, 2022 Q3 2022 |
1,559
shares
|
$514
0.0% of portfolio
|
Q3 2022
New holding
|
|
|
Highlander Capital Management, LLC
Short Hills, NJ |
May 20, 2024 Q1 2024 |
1,200
shares
|
$396
0.0% of portfolio
|
Q3 2023
New holding
|
|
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
Oct 10, 2024 Q3 2024 |
0
shares
|
$0
0.0% of portfolio
|
Q3 2024
New holding
|